Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778953) titled '90% Effective Infusion Time of Sufentanil to Prevent Induction Cough: A Biased Coin Sequential Study' on Aug. 19.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Shiyou Wei

Condition: Cough

Intervention: Drug: Sufentanil Citrate

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2026

Target Sample Size: 120

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07778953

Disclaimer: Curated by HT Syndication....